SCHEMBL8201574

SCHEMBL8201574

COc1ccc(S(=O)(=O)n2cc(CC3CCCN3C)c3ccccc32)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8208038 1.00 HTR6 (1.00) HTR6
SCHEMBL8208531 0.90 HTR6 (1.00) HTR6
SCHEMBL8208527 0.90 HTR6 (1.00) HTR6
SCHEMBL8201522 0.88 HTR6 (0.84) HTR6
SCHEMBL8201520 0.88 HTR6 (0.84) HTR6
SCHEMBL8201580 0.87 HTR6 (0.79) HTR6
SCHEMBL8201578 0.87 HTR6 (0.79) HTR6
SCHEMBL8208097 0.84 HTR6 (0.73) HTR6
SCHEMBL8201599 0.82 HTR6 (0.76) HTR6
SCHEMBL8201604 0.82 HTR6 (0.76) HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6100291-A FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS ALLELIX BIOPHARMACEUTICALS INC. (CA) 2000-08-08 US claimed
WO-1999047516-A1 3-(2-PYRROLIDINYLMETHYL)-INDOLE COMPOUNDS HAVING 5-HT6 AFFINITY SLASSI ABDELMALIK (CA) 1999-09-23 WO claimed
US-6100291-A FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS ALLELIX BIOPHARMACEUTICALS INC. (CA) 2000-08-08 US disclosed
EP-0932420-A4 DRUG DELIVERY USING TERMINAL COMPLEMENT COMPONENTS HARVARD COLLEGE (US) 2000-05-31 EP disclosed
WO-1999047516-A1 3-(2-PYRROLIDINYLMETHYL)-INDOLE COMPOUNDS HAVING 5-HT6 AFFINITY SLASSI ABDELMALIK (CA) 1999-09-23 WO disclosed
EP-0932420-A1 DRUG DELIVERY USING TERMINAL COMPLEMENT COMPONENTS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 1999-08-04 EP disclosed
WO-1997040857-A1 DRUG DELIVERY USING TERMINAL COMPLEMENT COMPONENTS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 1997-11-06 WO disclosed